Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
Springer Verlag
2018
|
_version_ | 1797065644071452672 |
---|---|
author | Becker, F Dakin, H Reed, S Li, Y Leal, J Gustavson, S Kartman, B Wittbrodt, E Gray, A Hernandez, A Holman, R |
author_facet | Becker, F Dakin, H Reed, S Li, Y Leal, J Gustavson, S Kartman, B Wittbrodt, E Gray, A Hernandez, A Holman, R |
author_sort | Becker, F |
collection | OXFORD |
description | |
first_indexed | 2024-03-06T21:31:31Z |
format | Conference item |
id | oxford-uuid:44d49889-da85-47f0-8620-e3cbf3f9a048 |
institution | University of Oxford |
last_indexed | 2024-03-06T21:31:31Z |
publishDate | 2018 |
publisher | Springer Verlag |
record_format | dspace |
spelling | oxford-uuid:44d49889-da85-47f0-8620-e3cbf3f9a0482022-03-26T15:04:06ZLifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trialConference itemhttp://purl.org/coar/resource_type/c_5794uuid:44d49889-da85-47f0-8620-e3cbf3f9a048Symplectic Elements at OxfordSpringer Verlag2018Becker, FDakin, HReed, SLi, YLeal, JGustavson, SKartman, BWittbrodt, EGray, AHernandez, AHolman, R |
spellingShingle | Becker, F Dakin, H Reed, S Li, Y Leal, J Gustavson, S Kartman, B Wittbrodt, E Gray, A Hernandez, A Holman, R Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial |
title | Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial |
title_full | Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial |
title_fullStr | Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial |
title_full_unstemmed | Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial |
title_short | Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial |
title_sort | lifetime cost effectiveness simulation of exenatide once weekly in type 2 diabetes evidence from the exscel trial |
work_keys_str_mv | AT beckerf lifetimecosteffectivenesssimulationofexenatideonceweeklyintype2diabetesevidencefromtheexsceltrial AT dakinh lifetimecosteffectivenesssimulationofexenatideonceweeklyintype2diabetesevidencefromtheexsceltrial AT reeds lifetimecosteffectivenesssimulationofexenatideonceweeklyintype2diabetesevidencefromtheexsceltrial AT liy lifetimecosteffectivenesssimulationofexenatideonceweeklyintype2diabetesevidencefromtheexsceltrial AT lealj lifetimecosteffectivenesssimulationofexenatideonceweeklyintype2diabetesevidencefromtheexsceltrial AT gustavsons lifetimecosteffectivenesssimulationofexenatideonceweeklyintype2diabetesevidencefromtheexsceltrial AT kartmanb lifetimecosteffectivenesssimulationofexenatideonceweeklyintype2diabetesevidencefromtheexsceltrial AT wittbrodte lifetimecosteffectivenesssimulationofexenatideonceweeklyintype2diabetesevidencefromtheexsceltrial AT graya lifetimecosteffectivenesssimulationofexenatideonceweeklyintype2diabetesevidencefromtheexsceltrial AT hernandeza lifetimecosteffectivenesssimulationofexenatideonceweeklyintype2diabetesevidencefromtheexsceltrial AT holmanr lifetimecosteffectivenesssimulationofexenatideonceweeklyintype2diabetesevidencefromtheexsceltrial |